Vermillion Raising up to $18.9M in Equity Financing | GenomeWeb

NEW YORK (Genomeweb News) – Vermillion today announced an equity financing of up to $18.9 million.

The company said that investors including Oracle Investment Management, Jack W. Schuler, Birchview Fund, and several Vermillion directors have agreed to purchase in a private placement approximately $10.5 million of unregistered shares of its common stock, and warrants to purchase up to $8.4 million in additional shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.